AngioDynamics, Inc. (ANGO) Tops Q1 EPS by 1c; Lowers FY13 EPS outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Analysts Sees Synergies and Struggles in AngioDynamics' (ANGO) Latest Acquisition
October 9, 2012 10:41 AM EDTAngioDynamics (NASDAQ: ANGO) recently reported first quarter earnings, with revenue in line with guidance. ANGO also announced the acquisition of Vortex Medical.
"On the plus side, we see potentially positive synergies with ANGO's existing PV line. That said, the purchase price... More
